Novel equations for estimating renal function: significance for drug dose adjustment

Important therapeutic decisions depend on kidney function, which is why its correct assessment is of great importance. It also plays an important role for drug dose adjustments in patients with impaired kidney function. In clinical practice, kidney function is almost always estimated using mathemati...

Full description

Saved in:
Bibliographic Details
Published in:Innere Medizin (Heidelberg, Germany) Germany), 2024-03, Vol.65 (3), p.280-285
Main Author: Ebert, Natalie
Format: Article
Language:ger
Subjects:
Aged
Biomarkers
Child
Creatinine
Cystatin C
Glomerular Filtration Rate - physiology
Humans
Kidney
Renal Insufficiency, Chronic
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Important therapeutic decisions depend on kidney function, which is why its correct assessment is of great importance. It also plays an important role for drug dose adjustments in patients with impaired kidney function. In clinical practice, kidney function is almost always estimated using mathematical glomerular filtration rate (GFR) equations. To estimate GFR, the patient's age and gender as well as kidney-specific endogenous biomarkers are required. This work aims to provide an overview of the advantages and disadvantages of the biomarkers serum creatinine and cystatin C in assessing kidney function. Particularly in patients with significantly reduced or increased muscle mass, creatinine is not suitable for determining GFR, and cystatin C should be used. Currently recommended GFR estimating equations are described, illustrating for which patient groups they can be used. A large number of high-ranking publications are available investigating the validity of GFR estimating equations and the optimal choice of endogenous biomarkers. However, there are still large gaps when it comes to drug approval studies in older patients and children. Estimated GFR (eGFR) is only a rough estimate of kidney function and should not be interpreted as an exact number. Drug dose adjustments may be necessary in patients with an eGFR of < 50 ml/min and should be verified particularly in severely impaired GFR (
ISSN:2731-7099
DOI:10.1007/s00108-023-01649-0